Latest Orally disintegrating tablet Stories
MIAMI, Aug. 17, 2011 /PRNewswire/ -- Fuisz Pharma (www.fuisz.com) today announced the publication of U.S. Patent Application US 20110182827 ("Method and Dosage Form to Confirm Compliant Use of a Bioactive Agent").
MISSISSAUGA, Ontario, July 25, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.
MIAMI, April 6, 2011 /PRNewswire/ -- Fuisz Pharma LLC announced today a new generation of solid dosage form designs that facilitate swallowing and esophageal transit.
MIAMI, Feb. 7, 2011 /PRNewswire/ -- Based on U.S.
WARREN, N.J. and PORTAGE, Ind., Dec.
MORRISTOWN, N.J., March 17 /PRNewswire/ -- Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Alprazolam orally disintegrating tablets.
WILMINGTON, Del., Aug. 11 /PRNewswire/ -- SPI Pharma, Inc., a leader in oral dispersible tablet (ODT) technologies with its patented Pharmaburst(R) and Pharmafreeze(TM) platforms, recently announced the launch of Pharmaburst(R) 500.
WARREN, N.J., July 23 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm((R)) technology and a drug delivery company specializing in dissolving thin film pharmaceutical products, today announced the appointment of Theodore "Ted" Clemente, Jr. as Vice President, Business Development. Mr.
SOUTH BRUNSWICK, N.J., July 16 /PRNewswire/ -- Tris Pharma, Inc., a drug delivery and specialty pharmaceutical company, today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.